INCREASED LEVELS OF URINARY COLLAGEN CROSS-LINKS IN FEMALES WITH RHEUMATOID-ARTHRITIS

被引:36
作者
SPECTOR, TD
JAMES, IT
HALL, GM
THOMPSON, PW
PERRETT, D
HART, DJ
机构
[1] Department of Rheumatology, St Thomas' Hospital, London, SE1 7EH, Lambeth Palace Rd
[2] Department of Rheumatology, St Bartholomew's Hospital Medical College, London
[3] Department of Rheumatology, Poole General Hospital, Poole
基金
英国惠康基金;
关键词
PYRIDINIUM CROSS-LINKS; STEROIDS; BONE;
D O I
10.1007/BF02231535
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone loss is a feature of RA, but the exact mechanisms involved are not clear. The collagen crosslinks deoxypyridinoline (DPYR) and pyridinoline (PYR) are specific indices of 'mature' collagen breakdown and reflect increased bone turnover. The aims of the study were to examine crosslink levels in RA and their association with disease activity and the effect of steroids. Urinary crosslinks corrected for creatinine were measured on morning fasting samples by HPLC in 70 postmenopausal women with rheumatoid arthritis (RA) aged 45-65 and compared with 169 postmenopausal healthy age-matched controls from the population. Mean levels of PYR were significantly higher in RA cases than in controls (52.4 versus 37.5 nmols/mmolCr) although mean levels of DPYR did not differ significantly. A weak correlation was found with ESR and PYR (r = 0.35) but not with other markers of disease activity. Thirteen of the RA cases were current steroid users and their levels of DPYR and PYR even with low doses, were significantly elevated above those of non-users, ex-users and controls. The finding of raised urinary PYR but not the bone specific DPYR in nonsteroid using RA cases suggests that the increased collagen breakdown does not primarily come from bone but from other sources such as cartilage and synovium. The large increases in collagen excretion in low dose steroid users, may reflect the higher risk of osteoporosis in this group.
引用
收藏
页码:240 / 244
页数:5
相关论文
共 20 条
  • [1] Adachi J.D., Markers of bone turnover in rheumatoid arthritis, J Rheumatol, 18, pp. 1119-1120, (1991)
  • [2] Magaro M., Altomorite L., Mirone L., Et al., Bone GLA protein (BGP) levels and bone turnover in rheumatoid arthritis, Br J Rheumatol, 28, pp. 207-211, (1989)
  • [3] Als O.S., Riis B.J., Gotresdon A., Christiansen C., Defos L.J., Biochemical markers of bone turnover in rheumatoid arthritis, Acta Med Scand, 219, pp. 209-213, (1989)
  • [4] Weismann M.H., Orth R.W., Catherwood B.D., Et al., Measures of bone loss in rheumatoid arthritis, Archives of Internal Medicine, 146, pp. 701-704, (1986)
  • [5] Eyre D.R., Ogushi H., The hydroxypyridinium crosslinks of skeletal collagens: their measurement, properties and a proposed pathway of formation, Biochem Biophys Res Communi, 92, pp. 403-410, (1980)
  • [6] Eyre D.R., Koob T.J., Van Ness K.P., Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography, Anal Biochem, 137, pp. 380-388, (1984)
  • [7] Black D., Duncan A., Robins S.P., Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion paired reversed phase high performance liquid chromatography, Anal Biochem, 169, pp. 197-203, (1988)
  • [8] James I.T., Perrett D., Thompson P.W., Rapid assay for hard tissue derived collagen crosslinks using isocratic ion pair reversed phase liquid chromatography, J Chromatogr (Biomed Appl), 525, pp. 43-57, (1990)
  • [9] Borggreven J.M.P.M., Hoppenbrouwers P.M.M., Gorisseu R., Radiochemical determination of the metabolic activity of collagen in mature dentin, J Dent Res, 58, pp. 2120-2124, (1979)
  • [10] Robins S.P., Duncan A., Riggs B.L., Direct measurement of free hydroxypyridinium crosslinks of collagen in urine as new markers of bone resorption in osteoporosis, Osteoporosis, 1990, pp. 465-467, (1990)